FONR Logo

FONR Stock Forecast: Fonar Corporation Price Predictions for 2026

Home โ€บ Stocks โ€บ United States | NASDAQ | Healthcare | Diagnostics & Research

$15.85

-0.29 (-1.80%)

FONR Stock Forecast 2025-2026

$15.85
Current Price
$99.98M
Market Cap
0 Ratings
Buy 0
Hold 0
Sell 0
Wall St Analyst Ratings

Distance to FONR Price Targets

N/A
To High Target of $N/A
N/A
To Median Target of $N/A
N/A
To Low Target of $N/A

FONR Price Momentum

+1.6%
1 Week Change
+8.9%
1 Month Change
-4.7%
1 Year Change
+4.7%
Year-to-Date Change
-15.1%
From 52W High of $18.68
+32.1%
From 52W Low of $12.00
๐Ÿ“Š TOP ANALYST CALLS

Did FONR Make This Month's Elite Buy List?

We don't follow just any analyst โ€” only the top 3% with a proven track record make our cut. See if FONAR is one of their latest high-conviction picks.

Join 5,000+ investors getting our data-driven analysis. Unsubscribe anytime.

Latest FONR Stock Price Targets & Analyst Predictions

FONR has shown a year-to-date change of 4.7% and a 1-year change of -4.7%, reflecting downward momentum over the past year. Comprehensive analyst forecasts are currently unavailable for FONR. Please refer to the price chart above for recent performance and trends.

Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.

FONR Analyst Ratings

0
Buy
0
Hold
0
Sell

FONR Price Target Range

Low
N/A
Average
N/A
High
N/A
Current: $15.85

Latest FONR Stock Forecasts by Analyst

These are the latest 20 analyst ratings and price targets for FONR.

Date Firm Analyst Rating Change Price Target

Fonar Corporation (FONR) Competitors

The following stocks are similar to FONAR based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.

Fonar Corporation (FONR) Financial Data

Fonar Corporation has a market capitalization of $99.98M with a P/E ratio of 12.7x. The company generates $103.02M in trailing twelve-month revenue with a 8.2% profit margin.

Revenue growth is +5.6% quarter-over-quarter, while maintaining an operating margin of +13.5% and return on equity of +6.9%.

Valuation Metrics

Market Cap $99.98M
Enterprise Value $67.98M
P/E Ratio 12.7x
PEG Ratio 0.8x
Price/Sales 1.0x

Growth & Margins

Revenue Growth (YoY) +5.6%
Gross Margin +44.5%
Operating Margin +13.5%
Net Margin +8.2%
EPS Growth +33.9%

Financial Health

Cash/Price Ratio +54.5%
Current Ratio 10.0x
Debt/Equity 24.8x
ROE +6.9%
ROA +3.5%
๐Ÿ’ก SKIP THE NOISE

97% of Analyst Ratings Go Nowhere

We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings โ€” tracked and updated every Monday and Thursday.

Join 5,000+ investors getting our data-driven analysis. Unsubscribe anytime.

Fonar Corporation logo

Fonar Corporation (FONR) Business Model

About Fonar Corporation

What They Do

Develops advanced MRI scanners and imaging equipment.

Business Model

Fonar Corporation generates revenue by manufacturing and selling MRI scanners and related medical imaging equipment to healthcare providers such as hospitals and diagnostic centers. Their innovative products, which allow for multi-position scanning, enhance diagnostic capabilities and improve patient outcomes, making them essential for modern medical practices.

Additional Information

Founded in 1978, Fonar Corporation was a pioneer in MRI technology, creating the first MRI scanner and continuing to drive advancements in the field. Based in Melville, New York, the company is a key player in medical imaging, emphasizing research and development to meet the evolving needs of healthcare professionals.

Company Information

Sector

Healthcare

Industry

Diagnostics & Research

Employees

520

CEO

Mr. Timothy R. Damadian M.D.

Country

United States

IPO Year

1993

Fonar Corporation (FONR) Latest News & Analysis

Featured Analysis
Powered by Zacks Investment Research

Top Research Reports for SAP, Novo Nordisk & Thermo Fisher

SAP gains on cloud strength, NVO faces obesity setbacks, and TMO leans on AI and innovation amid macro headwinds.

Jul 09, 2025 By Mark Vickery Research Daily

Latest News

FONR stock latest news image
Quick Summary

FONAR Corporation received a preliminary proposal for acquisition from a group led by Timothy Damadian, offering a price at least 10% above the average share price over the past 90 days.

Why It Matters

A proposed acquisition at a premium signals potential value appreciation for FONAR shareholders, indicating confidence in the company's future and possible changes in management strategy.

Source: Newsfile Corp
Market Sentiment: Neutral
FONR stock latest news image
Quick Summary

FONAR Corporation (NASDAQ: FONR) appointed Mr. Robert M. Carrino as an independent director on July 2, 2025.

Why It Matters

The appointment of Robert M. Carrino as an independent director could enhance governance and strategic direction at FONAR, potentially influencing investor confidence and stock performance.

Source: Newsfile Corp
Market Sentiment: Neutral
FONR stock latest news image
Quick Summary

FONAR Corporation reported increased net income and revenue for Q3 fiscal 2025, attributed to record MRI scan volumes and robust performance from its HMCA unit.

Why It Matters

FONAR's Q3 results indicate robust financial health with increased net income and revenue, signaling potential for growth and profitability, which can boost investor confidence and stock valuation.

Source: Zacks Investment Research
Market Sentiment: Positive
FONR stock latest news image
Quick Summary

Net Income rose 25% to $3.1 million for Q1 2025, while Income from Operations decreased 2% to $3.7 million compared to Q1 2024.

Why It Matters

Net Income growth indicates strong profitability, while a slight decline in Operating Income may raise concerns about core business performance. Balancing these factors is crucial for valuation.

Source: Newsfile Corp
Market Sentiment: Neutral
FONR stock latest news image
Quick Summary

FONAR's Q2 fiscal 2025 revenues and net income have declined due to increased costs and reduced scan volumes.

Why It Matters

FONAR's declining revenues and net income indicate potential financial instability, raising concerns about profitability and future performance impacting investor confidence.

Source: Zacks Investment Research
Market Sentiment: Negative
FONR stock latest news image
Quick Summary

MRI scan volume at HMCA managed sites rose 7% to 79,207 in the six months ended December 31, 2024. In contrast, volume at HMCA owned sites fell 4% to 26,961 scans.

Why It Matters

Increased MRI scan volume at managed sites signals growth potential, while the decrease at owned sites may raise concerns about operational efficiency and profitability.

Source: Newsfile Corp
Market Sentiment: Neutral

Frequently Asked Questions About FONR Stock

What is Fonar Corporation's (FONR) stock forecast for 2026?

Analyst forecasts for Fonar Corporation (FONR) are not currently available. The stock is trading at $15.85.

Is FONR stock a good investment in 2026?

Analyst ratings for FONR are not currently available. The stock is currently trading at $15.85. Investment decisions should be based on thorough research and your personal financial goals. Always conduct your own research and consider your investment goals before making investment decisions.

What is the long-term price prediction for FONR stock?

Price predictions from Wall Street analysts for FONR are not currently available. The stock is trading at $15.85.

What is Fonar Corporation's business model?

Fonar Corporation generates revenue by manufacturing and selling MRI scanners and related medical imaging equipment to healthcare providers such as hospitals and diagnostic centers. Their innovative products, which allow for multi-position scanning, enhance diagnostic capabilities and improve patient outcomes, making them essential for modern medical practices.

What is the highest forecasted price for FONR Fonar Corporation?

Price targets from Wall Street analysts for FONR are not currently available. The stock is trading at $15.85.

What is the lowest forecasted price for FONR Fonar Corporation?

Price targets from Wall Street analysts for FONR are not currently available. The stock is trading at $15.85.

What is the overall FONR consensus from analysts for Fonar Corporation?

Analyst ratings for FONR are not currently available. The stock is trading at $15.85.

How accurate are FONR stock price projections?

Stock price projections, including those for Fonar Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.

Important Disclaimer

The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.

Last updated: July 13, 2025 6:18 AM UTC
Serious About Growing Your Portfolio?

We highlight 2 high-upside stocks each month – no fluff.

Missed GME or NVDA? Donโ€™t Miss the Next One.โ€‹

Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities โ€” for free.